{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:43:44Z","timestamp":1700585024950},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2230.2009.03556.x","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T13:10:57Z","timestamp":1251897057000},"page":"e489-e490","source":"Crossref","is-referenced-by-count":4,"title":["Facial acne during topical pimecrolimus therapy for vitiligo"],"prefix":"10.1093","volume":"34","author":[{"given":"J.-C.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-E.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03556.x-BIB1","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03556.x-BIB2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00003495-200262050-00007","article-title":"Topical pimecrolimus. A review of its clinical potential in the management of atopic dermatitis","volume":"62","author":"Wellington","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2230.2009.03556.x-BIB3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2230.2009.03556.x-BIB4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archderm.143.9.1223","article-title":"Focal acne during topical tacrolimus therapy for vitiligo","volume":"143","author":"Bakos","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03556.x-BIB5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaad.2004.08.012","article-title":"Randomized controlled trial of pimecrolimus 1% cream for treatment of facial acne vulgaris","volume":"52","author":"Tan","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03556.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03556.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:06:23Z","timestamp":1676383583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/7\/e489\/6625122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03556.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}